Cargando…

Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study

Introduction: Bleeding occurs frequently in liver surgery. Unbalance between tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) concentrations might increase bleeding. Our aim was to analyze perioperative fibrinolytic changes during liver surgery. Materials and Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozolina, Agnese, Nemme, Janis, Ozolins, Arturs, Bjertnæs, Lars J., Vanags, Indulis, Gardovskis, Janis, Viksna, Ludmila, Krumina, Angelika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141717/
https://www.ncbi.nlm.nih.gov/pubmed/30255021
http://dx.doi.org/10.3389/fmed.2018.00253
_version_ 1783355756166250496
author Ozolina, Agnese
Nemme, Janis
Ozolins, Arturs
Bjertnæs, Lars J.
Vanags, Indulis
Gardovskis, Janis
Viksna, Ludmila
Krumina, Angelika
author_facet Ozolina, Agnese
Nemme, Janis
Ozolins, Arturs
Bjertnæs, Lars J.
Vanags, Indulis
Gardovskis, Janis
Viksna, Ludmila
Krumina, Angelika
author_sort Ozolina, Agnese
collection PubMed
description Introduction: Bleeding occurs frequently in liver surgery. Unbalance between tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) concentrations might increase bleeding. Our aim was to analyze perioperative fibrinolytic changes during liver surgery. Materials and Methods: We evaluated 15 patients for inclusion into a prospective pilot study of liver surgery. We assessed fibrinolysis by plasma PAI-1 and t-PA: before surgery (T1), before Pringle maneuver (PM;T2), at the end of surgery (T3) and 24 h postoperatively (T4), and registered demographic and laboratory data, extent and duration of surgery, hemodynamic parameters, blood loss, and transfused volumes of blood products. Data presented as mean ± SD. Significance at P < 0.05. Results: After exclusion of six patients only undergoing biopsies, we included six women and three men aged 49.1 ± 19.6 years; two patients with liver metastases of colorectal cancer and hepatocellular carcinoma, respectively, two with focal nodular hyperplasia, two with hepatic hemangioma, and one with angiomyolipoma. Six patients underwent PM. PAI-1 plasma concentration (n = 9) rose from 6.25 ± 2.25 at T1 through 17.30 ± 14.59 ng/ml at T2 and 28.74 ± 20.4 (p = 0.007) and 22.5 ± 16.0 ng/ml (p = 0.04), respectively, at T3 and T4. Correspondingly, t-PA plasma concentration (n = 9) increased from 4.76 ± 3.08 ng/ml at T1 through 8.00 ± 5.10 ng/ml (p = 0.012) at T2 and decreased to 4.25 ± 2.29 ng/ml and 3.04 ± 3.09 at T3 and T4, respectively. Plasma t-PA level at T2 was significantly different from those at T1, T3, and T4 (p < 0.004). In PM patients, t-PA levels increased from T1, peaked at T2 (p = 0.001), and subsequently decreased at T3 and T4 (p = 0.011 and p = 0.037), respectively. Mean blood loss was 1,377.7 ± 1,062.8 ml; seven patients received blood products. Patients with higher PAI-1 levels at T3 received more fresh frozen plasma (r = 0.79; p = 0.01) and red blood cells (r = 0.88; p = 0.002). Conclusions: During liver surgery, fibrinolysis increased, as evidenced by rises in plasma PAI-1and t-PA, especially after start of surgery and following PM. Transfused volumes of blood products correlated with higher plasma concentrations of PAI-1. Confirming this tendency requires a larger cohort of patients.
format Online
Article
Text
id pubmed-6141717
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-61417172018-09-25 Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study Ozolina, Agnese Nemme, Janis Ozolins, Arturs Bjertnæs, Lars J. Vanags, Indulis Gardovskis, Janis Viksna, Ludmila Krumina, Angelika Front Med (Lausanne) Medicine Introduction: Bleeding occurs frequently in liver surgery. Unbalance between tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) concentrations might increase bleeding. Our aim was to analyze perioperative fibrinolytic changes during liver surgery. Materials and Methods: We evaluated 15 patients for inclusion into a prospective pilot study of liver surgery. We assessed fibrinolysis by plasma PAI-1 and t-PA: before surgery (T1), before Pringle maneuver (PM;T2), at the end of surgery (T3) and 24 h postoperatively (T4), and registered demographic and laboratory data, extent and duration of surgery, hemodynamic parameters, blood loss, and transfused volumes of blood products. Data presented as mean ± SD. Significance at P < 0.05. Results: After exclusion of six patients only undergoing biopsies, we included six women and three men aged 49.1 ± 19.6 years; two patients with liver metastases of colorectal cancer and hepatocellular carcinoma, respectively, two with focal nodular hyperplasia, two with hepatic hemangioma, and one with angiomyolipoma. Six patients underwent PM. PAI-1 plasma concentration (n = 9) rose from 6.25 ± 2.25 at T1 through 17.30 ± 14.59 ng/ml at T2 and 28.74 ± 20.4 (p = 0.007) and 22.5 ± 16.0 ng/ml (p = 0.04), respectively, at T3 and T4. Correspondingly, t-PA plasma concentration (n = 9) increased from 4.76 ± 3.08 ng/ml at T1 through 8.00 ± 5.10 ng/ml (p = 0.012) at T2 and decreased to 4.25 ± 2.29 ng/ml and 3.04 ± 3.09 at T3 and T4, respectively. Plasma t-PA level at T2 was significantly different from those at T1, T3, and T4 (p < 0.004). In PM patients, t-PA levels increased from T1, peaked at T2 (p = 0.001), and subsequently decreased at T3 and T4 (p = 0.011 and p = 0.037), respectively. Mean blood loss was 1,377.7 ± 1,062.8 ml; seven patients received blood products. Patients with higher PAI-1 levels at T3 received more fresh frozen plasma (r = 0.79; p = 0.01) and red blood cells (r = 0.88; p = 0.002). Conclusions: During liver surgery, fibrinolysis increased, as evidenced by rises in plasma PAI-1and t-PA, especially after start of surgery and following PM. Transfused volumes of blood products correlated with higher plasma concentrations of PAI-1. Confirming this tendency requires a larger cohort of patients. Frontiers Media S.A. 2018-09-11 /pmc/articles/PMC6141717/ /pubmed/30255021 http://dx.doi.org/10.3389/fmed.2018.00253 Text en Copyright © 2018 Ozolina, Nemme, Ozolins, Bjertnæs, Vanags, Gardovskis, Viksna and Krumina. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Ozolina, Agnese
Nemme, Janis
Ozolins, Arturs
Bjertnæs, Lars J.
Vanags, Indulis
Gardovskis, Janis
Viksna, Ludmila
Krumina, Angelika
Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study
title Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study
title_full Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study
title_fullStr Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study
title_full_unstemmed Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study
title_short Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study
title_sort fibrinolytic system changes in liver surgery: a pilot observational study
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141717/
https://www.ncbi.nlm.nih.gov/pubmed/30255021
http://dx.doi.org/10.3389/fmed.2018.00253
work_keys_str_mv AT ozolinaagnese fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy
AT nemmejanis fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy
AT ozolinsarturs fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy
AT bjertnæslarsj fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy
AT vanagsindulis fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy
AT gardovskisjanis fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy
AT viksnaludmila fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy
AT kruminaangelika fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy